Sweden: OssDsign raises SEK150m in directed share issue following strategic shift

Shortly after OssDsign’s announcement of a strategic shift to focus its operations on the orthobiologics business in the US, the developer and global provider of next generation bone replacement products, completed a directed share issue of 26,315,790 shares at a subscription price of SEK5.7 per share, through which it raised approximately SEK150m (US$13.6m) before deduction…